Fingerprint
Dive into the research topics of 'Palivizumab in congenital heart disease: Should international guidelines be revised?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Palivizumab in congenital heart disease: Should international guidelines be revised?
Joseph M. Geskey, Neal J. Thomas, Gretchen L. Brummel
Research output: Contribution to journal › Review article › peer-review
11
Scopus
citations